CCI-779 polymorph and use thereof

Details CCI-779 polymorph and use thereof CCI-779 polymorph and use thereof

2006-01-25

2008-10-28

Kifle, Bruck (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C540S456000

Reexamination Certificate

active

07442707

ABSTRACT:
The present invention provides CCI-779 polymorph Form II. This invention also provides processes for preparing CCI-779 polymorph Form II and pharmaceutical compositions including CCI-779 polymorph Form II.

REFERENCES:
patent: 5362718 (1994-11-01), Skotnicki et al.
patent: 6277983 (2001-08-01), Shaw et al.
patent: 6677357 (2004-01-01), Zhu et al.
patent: 6680330 (2004-01-01), Zhu et al.
patent: 2005/0014777 (2005-01-01), Zhu et al.
patent: 2005/0033046 (2005-02-01), Chew et al.
patent: 2005/0049271 (2005-03-01), Benjamin et al.
patent: 2005/0234234 (2005-10-01), Gu et al.
patent: 1 216 251 (2003-02-01), None
patent: 0 763 039 (2003-03-01), None
patent: 1 419 154 (2005-10-01), None
patent: WO 95/28406 (1995-10-01), None
patent: WO 01/23395 (2001-04-01), None
patent: WO 03/018573 (2003-03-01), None
patent: WO 03/018574 (2003-03-01), None
patent: WO 2005/010010 (2005-02-01), None
patent: WO 2005/016935 (2005-02-01), None
patent: WO 2005/023254 (2005-03-01), None
patent: WO 2005/105811 (2005-11-01), None
Communication- International Search Report in International Application No. PCT/US2006/003098, mailed Jun. 27, 2006.

Affiliated with

Also associated with

Rating

CCI-779 polymorph and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CCI-779 polymorph and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CCI-779 polymorph and use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4006250